ȯ Ű ȭ ġ ߺ δٴ ˷ ִ.? ̷ ε ɰ ġ ̾.? ֱ,? ȯ̳ ִ ȯ ?10 ǰ ִٴ Դ. (Cardiovascular risk and obesity impact loss of grey matter volume earlier in males than females,? ,? ȸ Ҹ ) м?'Ű,?Űܰ (Journal of Neurology, Neurosurgery & Psychiatry)' ƴ. 丮 Į (Imperial College London)??45?82 ?3?4,425 ȯ ΰ ǰ ġ мߴ.? ̿ũ(UK Biobank)?ͺ̽ Ǿ,?ڵ ?63. м ,? ų ȸ ǰ ϴ Ÿ.? ȸ ٱ ϴ ָ κ,?Ű漼 ü ִ ̴.? ȸ Ҵ ̸Ӻ Ű ȭ ȯ ʱ ȣ ֵȴ. ̹ ǰ ȭ ̰ ε巯.??55 ǰ ް ȭDZ , 74 ̷ ӵǾ.?Ư?55~64 ̿ ε巯 ȸ Ҹ .?ݸ,??65 ǰ ȭ ۵Ǿ?74 ū Ҵ.?̴ ?10 ǰ ȭ Ѵٴ ش. ,?̸Ӻ ߺ ̴ ˷ (ApoE) E4? ο ȯ ǰ ƴ. ApoE ü ݷ ü?E2, E3, E4? ,??ApoE4? ġ ߺ ִ?15 ϴ ˷ ִ.? ̹ ?ApoE? ο ΰ Ű ȭ ģٴ ߴ. ̹ ̲ (Paul Edison)??" ȯ ΰ ġ ٸ Ÿٴ ̹ ó Ȯ ´" ߴ.?״?"?50 ʹݺ ǰ ü ؾ ǰ ų ִ" ߴ.?ݸ,? ȯ ϴ , 60 ʹݺ ̿ ߿ϴٰ ٿ. 2 索 ġῡ Ǵ ̸Ӻ ġῡ ȿ ִٰ .?Ư, GLP-1?ü ۿ ̸Ӻ 濡 ġ ɼ ִٰ ߴ. ̹ ȯ ܼ ü ǰ ġ ƴ϶,? ǰ ش.?Ư ?50,??60 ǰ ū Ѵٴ ߿ϴ.
|